|
|
|
Volumn , Issue , 2005, Pages
|
|
Medical journal criticizes Merck over Vioxx data.
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
CYCLOOXYGENASE 2 INHIBITOR;
LACTONE;
ROFECOXIB;
SULFONE;
ARTICLE;
BIOMEDICAL AND BEHAVIORAL RESEARCH;
CLINICAL TRIAL;
DRUG INDUSTRY;
ETHICS;
HUMAN;
MERCK INC.;
NEW ENGLAND JOURNAL OF MEDICINE;
PERSONNEL;
POPULAR APPROACH/SOURCE;
PUBLICATION;
SCIENTIFIC MISCONDUCT;
UNITED STATES;
BIOMEDICAL AND BEHAVIORAL RESEARCH;
MERCK INC.;
NEW ENGLAND JOURNAL OF MEDICINE;
POPULAR APPROACH/SOURCE;
CLINICAL TRIALS;
CYCLOOXYGENASE 2 INHIBITORS;
DRUG INDUSTRY;
HUMANS;
LACTONES;
PERIODICALS;
RESEARCH PERSONNEL;
SCIENTIFIC MISCONDUCT;
SULFONES;
UNITED STATES;
|
|
EID: 33644964700
PISSN: 03624331
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
|
Times cited : (3)
|
|
References (0)
|
